Tuesday, 3 April 2018

Reuters Health Report: Justice Department seeks role in opioid settlement talks

Justice Department seeks role in opioid settlement talks

(Reuters) - The U.S. Justice Department on Monday sought court permission to participate in settlement negotiations aimed at resolving lawsuits by state and local governments against opioid manufacturers and distributors.

European Medicines Agency to review Sanofi-Regeneron's Dupixent, Cemiplimab

PARIS (Reuters) - The European Medicines Agency (EMA) will review the Dupixent (dupilumab) and Cemiplimab products being developed by drugmakers Sanofi and Regeneron, the companies said on Tuesday.

Supreme Court rejects appeal to release anti-abortion activists' videos

WASHINGTON - The U.S. Supreme Court on Monday rejected a bid by anti-abortion activists to win the release of videos they surreptitiously recorded at meetings of abortion providers.

U.S. government sets 3.40 percent hike in 2019 payments to Medicare insurers

(Reuters) - The U.S. government on Monday said it would increase by 3.40 percent on average 2019 payments to the health insurers that manage Medicare Advantage insurance plans for seniors and the disabled, a higher-than-expected rise reflecting a projection of higher medical cost growth.

Allergan seeks options for women's health unit: Bloomberg

(Reuters) - Allergan Plc is considering options for its women's health unit, including a sale, Bloomberg reported on Monday, citing people with knowledge of the matter.

Legal marijuana tied to drop in opioid prescriptions

(Reuters Health) - Opioid prescriptions may decline when states legalize marijuana, two U.S. studies suggest.

Celgene Chief Operating Officer Scott Smith abruptly resigns

(Reuters) - Celgene Corp said on Monday Chief Operating Officer Scott Smith is leaving the company, effective immediately.

Many doctors don't pay attention to home health care plans

(Reuters Health) - Physicians charged with approving treatment plans for skilled home health care often spend no more than a minute reviewing the plans, a study of U.S. doctors suggests.

Slightly high blood pressure before pregnancy tied to miscarriage risk

(Reuters Health) - Women with slightly elevated blood pressure before they get pregnant may have an increased risk of miscarriage even when they're not diagnosed with hypertension, a U.S. study suggests.

FDA refuses to review Alkermes' depression treatment, seeks more trials

(Reuters) - Alkermes Plc has been told to conduct more clinical trials of its experimental depression treatment after the U.S. Food and Drug Administration rejected its initial application for approval, citing a lack of evidence of its effectiveness.

Related Videos

'Roseanne' star says revived show reflects Trump's America

Fluorescent dye makes 'invisible' microplastics glow

Read Reuters on the go

Download the free Reuters News app today for breaking news, analysis and market data from the world's most trusted news organization.

Get the app